SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| (NASDAQ: AQST) | Delayed: 4.76 +0.14 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.62 | 52 Week High | $ | |||
| Open | $4.62 | 52 Week Low | $ | |||
| Day High | $4.85 | P/E | N/A | |||
| Day Low | $4.55 | EPS | $ | |||
| Volume | 2,319,150 | |||||
| SCYNEXIS (NASDAQ: SCYX) | Delayed: 4.22 -0.56 (11.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $7.29 | |||
| Open | $4.70 | 52 Week Low | $1.74 | |||
| Day High | $4.75 | P/E | N/A | |||
| Day Low | $4.11 | EPS | $0.00 | |||
| Volume | 344,183 | |||||
